Are discount rates related to expected growth in life expectancy? Non-clinical study 30 January 2013 Pages: 5 - 5
Questionable recommendations for cholinesterase inhibitor use in AD Review 30 January 2013 Pages: 5 - 5
Temozolomide more cost effective than combo therapy in glioblastoma Clinical study 30 January 2013 Pages: 5 - 5
Infliximab upward dose adjustment increases treatment costs Clinical study 30 January 2013 Pages: 6 - 6
HAART/PI provides long-term clinical benefit, savings in HIV Clinical study 30 January 2013 Pages: 7 - 7
Rizatriptan worth it in Canada for moderate-to-severe migraine Clinical study 30 January 2013 Pages: 7 - 7
“Significant cost savings” accrued with discontinuation of HAART Clinical study 30 January 2013 Pages: 9 - 9
Race and sex differences in MI treatments found in the US Clinical study 30 January 2013 Pages: 9 - 9
Universal pneumococcal vaccination of infants warranted in Italy Clinical study 30 January 2013 Pages: 9 - 9
Hospitalisation increases initiation of benzodiazepine use Clinical study 30 January 2013 Pages: 10 - 10
Which antenatal screening strategy best bet in Scotland? Clinical study 30 January 2013 Pages: 10 - 10
Maintenance ECT preferred option among elderly with MDD Clinical study 30 January 2013 Pages: 11 - 11
Antiretroviral adherence linked to QOL in HIV infections Clinical study 30 January 2013 Pages: 12 - 12
Patient perception of oral anticoagulation therapy correlates with QOL Clinical study 30 January 2013 Pages: 12 - 12
Infliximab's QOL effect clinically meaningful in rheumatic disorders Clinical study 30 January 2013 Pages: 13 - 13